Radiopharm Theranostics Ltd - RADX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$3.669M
QoQ value delta ($000)
+$1.946M (+112.94%)
Implied price effect (QoQ)
-98.71%
Shares
Total shares
51,539,577
QoQ shares delta
+51,227,071 (+16392.35%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (RADX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 6 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
HSBC HOLDINGS PLC 1,006 191,624 0.0%
SILVERARC CAPITAL MANAGEMENT, LLC 978 187,406 0.14%
Stonepine Capital Management, LLC 850 51,000,000 0.62%
Regal Partners Ltd 474 90,909 0.03%
PNC FINANCIAL SERVICES GROUP, INC. 83 16,000 0.0%
Virtu Financial LLC 76 14,591 0.0%
JANE STREET GROUP, LLC 75 14,469 0.0%
UBS Group AG 74 14,277 0.0%
Marex Group plc 53 10,285 0.0%
RHUMBLINE ADVISERS 0 6 0.0%
Strategic Wealth Partners, Ltd. 0 10 0.0%